AVNS AVNS アバノス・メディカル

 AVNSのチャート


 AVNSの企業情報

symbol AVNS
会社名 Avanos Medical Inc (AVNS アバノス・メディカル)
分野(sector)   
産業(industry)   
業種 医療機器_医療用品_ディストリビュ―タ―   医療関連(Health Care)
概要 事業概要 アバノス・メディカル(Avanos Medical Inc.)(旧名:Halyard Health Inc.)は医療技術会社である。同社は、主に手術・Interventional pain management、呼吸器及び消化器の健康を中心とする製品ポートフォリオを提供する。同社の製品には、術後の疼痛管理ソリューション、低侵襲介入または慢性疼痛治療、閉鎖式気道吸引システム及び経腸栄養チューブがある。同社の製品は「ON-Q」、「COOLIEF」、「MICROCUFF」、「MIC-KEY」、「QUIKBLOC」、「HOMEPUMP」及び「CORTRAK」などのブランド名で販売される。  ハリヤ―ド・ヘルスは米国の医療関連会社。感染管理、医療安全を考慮した製品を提供。主要製品は、サ―ジカルガウン、サ―ジカルドレ―ブ、アイソレ―ションガウン、防水ガウン、減菌包装材、フェイシャルプロテクション、検査検診用グロ―ブ、手術用微生物シ―ラント、閉鎖型気管内吸引カテ―テル、経腸栄養チュ―ブなど。100カ国以上の国で製品を販売。  Avanos Medical is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients' quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today's most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands in more than 90 countries.
本社所在地 844 428-2667
代表者氏名 Ronald W. Dollens
代表者役職名 Independent Chairman of the Board
電話番号 +1 678-425-9273
設立年月日 41671
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 4700人
url www.avanos.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 65.60000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 2025.30500
売上高 売上高(百万ドル) 652.30000
企業価値(EV) 企業価値(EV)(百万ドル) 1888.50500
当期純利益 当期純利益(百万ドル) -12.40000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Avanos Medical Inc revenues increased 7% to $652.3M. Net loss before extraordinary items decreased 71% to $12.4M. Revenues reflect North America segment increase of 7% to $505.3M Asia Pacific and Latin America segment increase of 10% to $59.7M. Lower net loss reflects Interest income increase from $2.5M to $7.8M (income) Interest expense decrease of 16% to $26.4M (expense).

 AVNSのテクニカル分析


 AVNSのニュース

   Avanos: Entry To Hyaluronic Acid Market Sparks Interesting Debate (NYSE:AVNS)  2022/09/12 09:37:24 Seeking Alpha
Avanos'' acquisition of TriVisc portfolio creates an interesting debate for those following hyaluronic acid market. Read more for AVNS stock''s full investment analysis.
   7 Safe Small-Cap Stocks to Buy Now  2022/08/11 01:29:05 InvestorPlace
Let’s begin by defining the realm of small-cap stocks before we discuss those that appear to be strong, safe investments currently. As their name implies, small-cap stocks have lower market capitalizations than both mid-cap and large-cap stocks. The range of market cap defining the class is typically from $300 million to $2 billion. Large-cap stocks carry a market cap of at least $10 billion. Mid-caps bridge the difference. A point to remember is that investing in small-cap stocks is inherently riskier than investing in their mid-cap and large-cap counterparts. That volatility is intriguing to many investors. But there are other reasons, outside of quick gains, to consider small-cap stocks. They aren’t all simply startup companies and fledgling investments. Some represent household names as well. And, according to Investopedia , they often perform as well or better than large-cap stocks over similar time horizons. Let’s take a look at seven safe small-cap stocks that investors should consider buying now.
   Avanos Medical: Q2 Earnings Insights  2022/08/09 11:32:48 Benzinga
Avanos Medical (NYSE: AVNS ) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings Avanos Medical beat estimated earnings by 7.89%, reporting an EPS of $0.41 versus an estimate of $0.38. Revenue was up $16.60 million from the same period last … Full story available on Benzinga.com
   Avanos Medical reports Q2 mixed earnings; narrows FY22 guidance (NYSE:AVNS)  2022/08/09 11:22:20 Seeking Alpha
Avanos Medical press release (AVNS): Q2 Non-GAAP EPS of $0.41 beats by $0.03.Revenue of $203M (+8.9% Y/Y) misses by $5.28M.Adjusted EBITDA for the second quarter was $33M, compared…
   Earnings Scheduled For August 9, 2022  2022/08/09 09:02:37 Benzinga
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ: CGTX ) is estimated to report earnings for its second quarter. • Gilat Satellite Networks (NASDAQ: GILT ) is estimated to report quarterly loss at $0.01 per share on revenue of $56.24 million. • Drive Shack (NYSE: DS ) is likely to report quarterly loss at $0.10 per share on revenue of $82.58 million. • ReWalk Robotics (NASDAQ: RWLK ) is projected to report earnings for its second quarter. • Creative Media (NASDAQ: CMCT ) is expected to report earnings for its second quarter. • Anavex Life Sciences (NASDAQ: AVXL ) is likely to report earnings for its third quarter. • Dare Bioscience (NASDAQ: DARE ) is expected to report quarterly loss at $0.06 per share on revenue of $10.00 million. • Quotient (NASDAQ: QTNT ) is projected to report earnings for its first quarter. • Ebix (NASDAQ: EBIX ) is projected to report quarterly earnings at $0.56 per share on revenue of $273.09 million. • Motorcar Parts of America (NASDAQ: MPAA ) is projected to report quarterly earnings at $0.
   Avanos Medical, Inc. to Present at the UBS 2022 Global Healthcare Conference  2022/05/17 14:54:00 PR Newswire
ALPHARETTA, Ga., May 17, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present and participate in a fireside chat at the UBS 2022 Global Healthcare Conference on Monday, May 23 at…
   Avanos Medical, Inc. 2022 Q1 - Results - Earnings Call Presentation (NYSE:AVNS)  2022/05/05 07:03:34 Seeking Alpha
The following slide deck was published by Avanos Medical, Inc.
   Recap: Avanos Medical Q1 Earnings  2022/05/04 11:45:33 Benzinga
Avanos Medical (NYSE: AVNS ) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings Avanos Medical reported in-line EPS of $0.26 versus an estimate of $0.26. Revenue … Full story available on Benzinga.com
   Avanos Medical Non-GAAP EPS of $0.26 in-line, revenue of $197.4M misses by $0.4M (NYSE:AVNS)  2022/05/04 11:08:05 Seeking Alpha
Avanos Medical press release (NYSE:AVNS): Q1 Non-GAAP EPS of $0.26 in-line.Revenue of $197.4M (+9.2% Y/Y) misses by $0.4M.
   Avanos Medical, Inc. Announces First Quarter 2022 Results  2022/05/04 11:00:00 PR Newswire
ALPHARETTA, Ga., May 4, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2022 financial results. "Coming off last year''s solid finish, we maintained our momentum through the first quarter while adding OrthogenRx to our portfolio," stated Joe Woody,…
   Recap: Avanos Medical Q4 Earnings  2022/02/23 12:33:23 Benzinga
Avanos Medical (NYSE: AVNS ) reported its Q4 earnings results on Wednesday, February 23, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings Avanos Medical beat estimated earnings by 15.0%, reporting an EPS of $0.46 versus Full story available on Benzinga.com
   Avanos Medical Non-GAAP EPS of $0.46 beats by $0.06, revenue of $193.4M beats by $2.08M  2022/02/23 12:08:42 Seeking Alpha
Avanos Medical press release (AVNS): Q4 Non-GAAP EPS of $0.46 beats by $0.06.Revenue of $193.4M (+4.5% Y/Y) beats by $2.08M.The company expects FY2022 net sales to be between $830M
   Avanos Medical Q4 2021 Earnings Preview  2022/02/22 16:24:57 Seeking Alpha
Avanos Medical (NYSE:AVNS) is scheduled to announce Q4 earnings results on Wednesday, February 23rd, before market open.The consensus EPS Estimate is $0.40 (+42.9% Y/Y) and the
   Avanos Medical Inc Shares Near 52-Week Low - Market Mover  2022/01/29 03:28:41 Kwhen Finance
Avanos Medical Inc (AVNS) shares closed today at 1.8% above its 52 week low of $28.95, giving the company a market cap of $1B. The stock is currently down 16.0% year-to-date, down 37.1% over the past 12 months, and down 23.8% over the past five years. This week, the Dow Jones Industrial Average fell 1.6%, and the S&P 500 fell 3.5%. Trading Activity Trading volume this week was 6.7% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.4% lower than its 5-day moving average, 9.8% lower than its 20-day moving average, and 8.9% lower than its 90-day moving average. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 83.6% The company's stock price performance over the past 12 months lags the peer average by 51.0% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Avanos Medical Inc Shares Approach 52-Week Low - Market Mover  2022/01/28 10:12:12 Kwhen Finance
Avanos Medical Inc (AVNS) shares closed today at 0.7% above its 52 week low of $28.95, giving the company a market cap of $1B. The stock is currently down 10.7% year-to-date, down 35.0% over the past 12 months, and down 17.0% over the past five years. This week, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 4.1%. Trading Activity Trading volume this week was 43.0% lower than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 55.6% The company's stock price performance over the past 12 months lags the peer average by 38.3% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

 関連キーワード  (医療機器_医療用品_ディストリビュ―タ― 米国株 AVNS アバノス・メディカル AVNS )

医療で使われる機器のこと。レントゲン装置やからだの断面を画像化できるMRI(磁気共鳴画像)装置など高機能機器を含め数多くの種類がある。医療現場で使われるため、正確で精密である点などが求められる。医療機器への需要は着実に高まっており、電機メーカーなどからの進出も進んでいる。

 twitter  (公式ツイッターやCEOツイッターなど)